James J. Lee, MD, PhD, assistant professor of medicine, Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, discusses the importance of mismatched repair testing in colorectal cancer (CRC).
Lee stresses the importance of informing other medical oncologists with the findings of this study, so that patients can be appropriately screened and ultimately improve their outcome.
James J. Lee, MD, PhD, assistant professor of medicine, Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, discusses the importance of mismatched repair testing in colorectal cancer (CRC).
Considering Targeted Therapies When Managing Young Patients With mCRC
March 27th 2023In an interview with Targeted Oncology, Jennifer Y. Wo, MD, highlighted emerging discussions in the metastatic colorectal cancer space, where targeted therapies play a role, and what the next steps for research include.
Read More
Ruxolitinib Extended-Release Could Mitigate Risk/Increase Compliance for Patients With MPNs
March 24th 2023In an interview with Targeted Oncology, Aaron T. Gerds, MD, MS, provided an in-depth discussion on the complete response letter issued to ruxolitinib extended-release, and why continued evaluation of the agent could be beneficial for patients with MPNs.
Read More
The Impact of the Gut Microbiome in Young Patients With Colorectal Cancer
February 15th 2021In season 2, episode 2 of Targeted Talks, Cathy Eng, MD, speaks with Benjamin Weinberg, MD, about the gut microbiome, and how the presence of certain microbiota impact the onset and intensity of disease as well as the potential response to certain treatments.
Listen
Updates on Recent Advances and Treatments for Hematologic Malignancies
March 22nd 2023In an interview with Targeted Oncology, Guenther Koehne, MD, PhD, provided an overview of The Summit of Americas on Immunotherapies for Hematologic Malignancies and some of the recent and exciting advances being seen in the hematology space.
Read More
2 Clarke Drive
Cranbury, NJ 08512